Developing revolutionary fusion technology in the U.S. and abroad.
A 105-acre campus in Janesville, Wisconsin, is home to our global headquarters, as well as The Chrysalis, Cassiopeia and Building One. The Chrysalis will be home to our proprietary fusion-driven medical isotope production process, focused in the near-term on producing molybdenum-99. We expect Cassiopeia to be the largest production facility for lutetium-177 in the world, with a capacity of up to 300,000 patient doses per year. And Building One is our state-of-the-art technology development center, as well as a bridge production facility for lutetium-177 until Cassiopeia comes online.
Fitchburg, Wisconsin, is home to Heliopolis facility and to the Phoenix Imaging Center. Heliopolis is the home of our Systems and Manufacturing division, where our fusion systems are researched, designed, developed, built and tested. Our Phoenix Imaging Center provides a full suite of neutron radiography services.
Veendam, the Netherlands, is the home of SHINE Europe, and is where we plan to construct our first European medical isotope production facility. It will replicate the layout and production capacity of our Chrysalis facility in Janesville to provide a reliable and flexible supply of critical medical isotopes to customers in Europe and beyond. The SHINE Europe team is engaged in the design and licensing process for the facility.
